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ABSTRACT 47 
 48 
Na-ASP-2 is an efficacious hookworm vaccine antigen; however, despite elucidation of its 49 
crystal structure and studies addressing its immunobiology, the function of Na-ASP-2 has 50 
remained elusive. We probed a 9,000 protein human proteome microarray with Na-ASP-2 51 
and showed binding to CD79A, a component of the B cell antigen receptor complex. Na-ASP-52 
2 bound to human B lymphocytes ex vivo and down-regulated the transcription of ~1,000 B 53 
cell mRNAs, while only ~100 mRNAs were up-regulated compared to control-treated cells. 54 
The expression of a range of molecules was affected by Na-ASP-2, including factors involved 55 
in leukocyte transendothelial migration pathways and the B cell signaling receptor pathway. 56 
Of note was the down-regulated transcription of lyn and pi3k, molecules that are known to 57 
interact with CD79A and control B cell receptor signaling processes. Together, these results 58 
highlight a previously unknown interaction between a hookworm-secreted protein and B cells, 59 
which has implications for helminth-driven immunomodulation and vaccine development. 60 
Further, the novel use of human protein microarrays to identify host-pathogen interactions, 61 
coupled to ex vivo binding studies and subsequent analyses of global gene expression in 62 
human host cells, demonstrates a new pipeline by which to explore the molecular basis of 63 
infectious diseases. 64 
 65 
Keywords. Hookworm, Necator americanus, Na-ASP-2, SCP/TAPS, CD79, B cell, antigen 66 
receptor, protein microarray, host-pathogen interaction  67 
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INTRODUCTION 68 
The hookworm Necator americanus is one of the most prevalent pathogens of humans, infecting 69 
between 576-740 million people worldwide [1]. Hookworms can persist for many years within their 70 
hosts [2], having evolved a suite of strategies to evade immune attack, from the point of per-71 
cutaneous entry and pulmonary migration by third-stage larvae (L3), through to their final site of 72 
residence as adult worms in the gut. While hookworm infection can be treated with anthelmintic 73 
drugs, reinfection rapidly occurs [3], precipitating an urgent need for development of vaccines to 74 
limit the global burden of human hookworm infections [4]. 75 
 76 
Efforts to develop vaccines against hookworm infection have focused on discovery of antigens 77 
secreted by the L3 stage. Serum antibodies from dogs vaccinated with irradiated hookworm L3 [5] 78 
and people from hookworm-endemic areas with high antibody titres but low egg counts [6] 79 
predominantly recognise members of the activation-associated protein (ASP) family, notably Na-80 
ASP-2. In a phase 1a vaccine trial in hookworm naïve subjects from the U.S., recombinant Na-81 
ASP-2 was well-tolerated and immunogenic [7], however, a phase 1b trial in hookworm-exposed 82 
individuals in Brazil was halted due the development of urticarial reactions in people with pre-83 
existing IgE against Na-ASP-2 [8]. Despite the safety concerns, there remains interest in Na-ASP-2 84 
as a vaccine candidate, particularly if used as a pediatric vaccine prior to the development of anti-85 
hookworm IgE responses, or if it is modified to reduce its allergenic capacity [9]; which has proven 86 
effective for peanut, dust mite and wasp allergens [10-12]. 87 
 88 
Despite the relatively long history of research into hookworm ASPs as vaccines, relatively little is 89 
known about their biological roles. ASP-2 is one of the most abundant excretory/secretory (ES) 90 
proteins produced by L3 upon exposure to host serum [13, 14], however its expression is 91 
diminished as the parasite migrates through the lung, provoking the hypothesis that ASP-2 may be 92 
involved in immune regulation while the parasite resides in the circulatory system. Administration 93 
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of recombinant Na-ASP-2 to rodents elicits a type 2 cytokine response, robust antibody production 94 
and neutrophil recruitment [5, 15], although direct interactions between Na-ASP-2 and a defined 95 
cell type were not elucidated. The hookworm ASP protein family forms 3 distinct structural groups 96 
based on X-ray crystallographic studies [16, 17]. The crystal structure of Na-ASP-2 indicates the 97 
presence of a putative electronegative binding cavity flanked by conserved His and Glu residues 98 
[17], suggesting that an unknown ligand or binding partner exists. Another hookworm-derived 99 
ASP-like protein - Neutrophil Inhibitory Factor - has been shown to directly interact with host 100 
CD11b, thereby inhibiting neutrophil function [18], hence it remains likely that Na-ASP-2 binds to 101 
a cell surface receptor from its human host to exert its effector function(s). 102 
 103 
Herein we describe the first probing of a human proteome microarray with a pathogen-derived 104 
protein to reveal a selective interaction between Na-ASP-2 and CD79A, a component of the B-cell 105 
antigen receptor complex. We confirm the interaction by showing that Na-ASP-2 binds to human B 106 
cells ex vivo and triggers changes in B cell-intrinsic gene expression, notably key signaling 107 
molecules of the antigen receptor pathway.  108 
 109 
METHODS  110 
 111 
Ethics 112 
Healthy Caucasian volunteers (aged 30-45) from Cairns, Australia, a region that is not endemic for 113 
human hookworm infection, were used as a source of peripheral blood under informed consent 114 
using a protocol (H4385) approved by the James Cook University Human Research Ethics 115 
Committee. 116 
 117 
Probing of a human protein microarray with recombinant Na-ASP-2 118 
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Purified, full-length recombinant Na-ASP-2 was a kind gift from Dr. Bin Zhan (Baylor College of 119 
Medicine, USA). The protein was expressed in Pichia pastoris and purified via two ion exchange 120 
chromatography steps followed by a final desalting step as described elsewhere [19]. Na-ASP-2 121 
was biotinylated with NHS-LC-biotin (Thermo-Fisher) and used to probe a Human V5 ProtoArray 122 
(Invitrogen) at a final concentration of 50 g.ml-1. The ProtoArray contains over 9,000 human 123 
proteins printed in duplicate, and includes more than 2,600 membrane proteins. Binding of 124 
biotinylated Na-ASP-2 to proteins on the array was detected with streptavidin Alexafluor 647 at a 125 
1:1000 dilution in Protoarray blocking buffer (Invitrogen). The array was scanned using a 126 
GeneArray 4000B scanner (Molecular Devices) at 635 nm. Results were saved as a multi-TIFF file 127 
and analyzed using Genepix Prospector software, version 7. 128 
 129 
Molecular Modelling 130 
Comparative modelling was applied to generate a three-dimensional atomic model of human 131 
CD79A, using the crystal structure of human CD79B (PDB accession code 3kg5) as a template. A 132 
secondary structure-based amino acid sequence alignment of CD79A and CD79B was prepared 133 
with SBAL [20] and used to guide the comparative modelling calculations. Twenty independent 134 
models were calculated with MODELLER [21], and the one with the lowest energy was selected 135 
and superimposed onto one of the monomers in the CD79B homodimer structure (rigid body 136 
modelling). The secondary structure topology and amino acid sequence of CD79A is compatible 137 
with the intermolecular interactions observed in the CD79 homodimer structure [22]. A minor 138 
manual adjustment was made to enable inter-molecular disulphide bond formation (CysA119-139 
CysB136) in the resulting heterodimer. Both cysteine residues were in prime position for this bond, 140 
which is also observed in the CD79B homodimer. The crystal structure of Na-ASP-2 was docked to 141 
the CD79 heterodimer model, using a rigid body approach based on a multi-dimensional spherical 142 
polar Fourier correlation with shape and electrostatics expansion as implemented in Hex [23]. The 143 
rigid body docking calculations were carried out without preferred contacts to enable an unbiased 144 
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complex formation. From the generated 100 independent models the highest scoring one (energy 145 
score: -873, next highest -720) was chosen. The figures were generated with PyMOL [24]. 146 
 147 
Blood lymphocyte isolation and culture 148 
Human peripheral blood mononuclear cells (PBMCs) were isolated by density centrifugation 149 
(Lymphoprep
TM
). Cells (1 × 106 cells.ml-1) were incubated for 4 or 24 h at 37°C in either 96-well 150 
plates (for flow cytometry) or 24-well plates (for sort purification) with Na-ASP-2 in DMEM with 151 
10% heat-inactivated fetal bovine serum, 2 mM L-glutamine, 100 U/mL penicillin, 100 U/mL 152 
streptomycin and 25mM HEPES (media). B-cell activation was induced by 24 h of stimulation with 153 
10 μg/ml of goat F(ab’)2 anti-human IgM (μ chain, Sigma). 154 
 155 
Flow cytometry and cell sorting 156 
Cells were stained with fluorophore-conjugated antibodies against CD19 (HIB19), CD20 (2H7), 157 
CD3 (OKT3), CD4 (OKT4), CD14 (61D3) CD69 (FN50), HLA-DR (LN3), CD80 (2D10.4), CD86 158 
(IT2.2) (all from eBioscience). In experiments using biotinylated Na-ASP-2, streptavidin-FITC was 159 
included in the staining panel. Cells were analysed using a BD-FACSCantoII flow cytometer. 160 
Alternatively, or CD3
-
 CD14
-
 CD19
+
 CD20
+
 cells were sort-purified using a BD-FACSAria III cell 161 
sorter. 162 
 163 
RNA isolation 164 
RNA was extracted from sort-purified CD19
+
 CD20
+
 B cells for high-throughput RNA-Seq at BGI 165 
(Hong Kong) or real-time quantitative PCR (qPCR) analysis. Pelleted cells were lysed in RLT 166 
buffer (QIAGEN) + beta-mercaptoethanol and stored at -80°C until RNA was extracted using the 167 
RNAeasy kit with DNAse purification (QIAGEN). The concentration and integrity of each RNA 168 
preparation were verified on a 2100 Bioanalyzer (Agilent) and each preparation was stored in 169 
RNAstable tubes (Biomatrica) at room temperature until subsequent use. 170 
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 171 
Illumina sequencing 172 
RNA was reverse-transcribed to cDNA using the Illumina TruSeq™ sample preparation kit. 173 
Briefly, 1.0 g of total RNA from each cell preparation was used for poly-A mRNA selection using 174 
streptavidin-coated magnetic beads. Two rounds of poly-A mRNA enrichment were performed, 175 
followed by thermal fragmentation of the mRNA to a length of 100-500 bp. Each fragmented RNA 176 
sample was then reverse transcribed to cDNA using random primers, end-repaired and adaptor-177 
ligated (Illumina). Ligated products were PCR-amplified (15 cycles) and cleaned using a MinElute 178 
column (QIAGEN). Amplicons were paired-end sequenced on an Illumina HiSeq 2500 (Illumina).  179 
 180 
Bioinformatic analyses 181 
Ninety bp single-reads were screened for the presence of adapter sequences and sequences with 182 
>10% unknown bases and sequences with >50% low-quality bases. The remaining reads were 183 
splice-aligned to the human genome reference assembly GRCh37 (NCBI build 37.1) using TopHat, 184 
which incorporates the Bowtie v0.11.3 algorithm [25]; subsequently, individual aligned read files 185 
were assembled into transcripts using Cufflinks [26]. Relative levels of transcription were measured 186 
using the Reads Per Kilobase per Million reads algorithm (RPKM) [27]. Differences in levels of 187 
gene transcription were determined as previously described [28]. The false discovery rate method 188 
(FDR) [29] was used to correct the errors associated with multiple pairwise comparisons (FDR < 189 
0.001) and a |log2ratio| > 1 was set as the threshold for the significance of gene expression changes. 190 
Differentially expressed genes (DEGs) were mapped to Gene Ontology terms and Kyoto 191 
Encyclopedia of Genes and Genomes (KEGG) biological pathways available in the GO and KEGG 192 
databases, respectively (www.geneontology.org; www.genome.jp/kegg/). A hypergeometric test 193 
was subsequently used to identify significantly enriched GO terms and KEGG pathways in DEGs 194 
compared to the transcriptome background using the GOTerm::Finder software [30]. The calculated 195 
P-values were subjected to Bonferroni correction using the corrected P-value of 0.05 as a threshold. 196 
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Raw sequence data have been deposited in the Sequence Read Archive (SRA) of NCBI under 197 
accession number SRAXXXXXX. 198 
 199 
Real-Time quantitative PCR 200 
Total RNA was extracted from sort-purified B cells from four hookworm-naïve Caucasian human 201 
volunteers that were cultured for 24 h in the presence or absence of Na-ASP-2. cDNAs were 202 
prepared using Superscript III reverse transcriptase (Invitrogen). SYBR Green mastermix 203 
(QIAGEN) was used with a Rotor-Gene q thermal cycler (QIAGEN). The oligonucleotides were 204 
designed manually and synthesized (Integrated DNA Technologies). Data were analyzed using the 205 
ΔΔCT method whereby actin served as the endogenous gene and samples were normalized to media 206 
controls. Primer sequences were as follows: -actin- forward ATTGGCAATGAGCGGTTC and 207 
reverse GGATGCCACAGGACTCCAT; lyn forward GAGACTCGGGGAGCCATTG and reverse 208 
ACGCTGGGGATGTTATACTCT; pi3kr5 (23533) forward CTTCCACGCTACGTGTTGTG and 209 
reverse TGAAGTTTGAAGAACCGTGTGAG.  210 
 211 
Statistical Analyses 212 
Statistical analyses of qPCR data were conducted using a paired t test where ΔΔCT values for each 213 
gene of interest were compared between test (Na-ASP-2 exposed) vs control (media exposed) cells. 214 
P values of <0.05 were deemed statistically significant.  215 
 216 
RESULTS 217 
 218 
Interaction between Na-ASP-2 and human CD79A revealed by probing of a human proteome 219 
microarray 220 
Probing of the human proteome array with biotinylated Na-ASP-2 revealed interactions between 221 
Na-ASP-2 and five human proteins. The strongest interaction was with propionyl-CoA carboxylase 222 
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(PCCA), an anticipated interaction because PCCA is a biotin-binding enzyme and would therefore 223 
be expected to bind to any biotinylated recombinant protein used to probe the array (Figure 1, 224 
Supplementary Table 1). Indeed, we have noted consistent binding of other (unrelated) 225 
biotinylated recombinant proteins to PCCA (unpublished). The second most intense association was 226 
with CD79A, which together with CD79B forms a hetero-dimer and a subunit of the B-cell antigen 227 
receptor. The third and fifth strongest hits were also proteins involved in biotin metabolism 228 
(Supplementary Table 1). The fourth strongest association was with cortactin, which is involved 229 
in actin remodeling and was of sufficiently low signal intensity (2.4 fold lower than CD79A) that 230 
we deemed it unworthy of further pursuit (Supplementary Table 1). Probing of a second array 231 
using identical conditions resulted in consistent binding between Na-ASP-2 and the same five 232 
human proteins on the array. 233 
 234 
Modelling of Na-ASP-2 interactions with CD79 235 
We recently panned a random 12-mer peptide phage display library with Na-ASP-2 and showed 236 
that most of the bound peptides were enriched for glutamine and histidine residues [31]. 237 
Interestingly, the extracellular domain of CD79A contains a HXQXXH motif at residues 51-56. 238 
This peptide forms part of a large surface of CD79A which has previously been implicated in 239 
binding of the B cell antigen receptor [22]. Rigid body docking of the crystal structure of Na-ASP-2 240 
and a model of heterodimeric CD79A/CD79B suggests that, based on shape and electrostatics, Na-241 
ASP-2 may bind to the CD79 heterodimer (Figure 2). Furthermore, this model indicates that Na-242 
ASP-2 mainly interacts with the CD79A surface harboring the HXQXXH motif, but a protruding 243 
loop of CD79B (residues 79-86) may also engage in interactions with the hookworm protein.  244 
 245 
Na-ASP-2 binds selectively to human B cells.  246 
CD79A is expressed exclusively on B lymphocytes. To verify the interaction between Na-ASP-2 247 
and CD79A, we cultured human PBMCs from healthy, hookworm-naïve human volunteers ex vivo 248 
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for 4 or 24 h with biotinylated Na-ASP-2 and performed flow cytometry. Cells were stained for B 249 
cell markers (CD19, CD20), T cell marker CD3, monocyte marker CD14, and streptavidin-FITC for 250 
detection of surface-bound Na-ASP-2. This experiment was performed twice, with two different 251 
blood donors. As expected, we detected negligible frequencies of FITC
+
 cells following treatment 252 
with media or non-biotinylated Na-ASP-2, however treatment with increasing amounts of 253 
biotinylated Na-ASP-2 resulted in a dose-dependent increase in the frequency of Na-ASP-2/FITC
+
 254 
cells (Figure 3A). Gated FITC
+
 cells were analyzed for various leukocyte surface markers. While 255 
only 8% of FITC
+
 cells expressed CD3 or CD14, the majority (72%) of FITC
+
 cells co-expressed 256 
CD20 and CD19, a phenotype consistent with human B lymphocytes (Figure 3B). Modifying 257 
culture time, temperature and cell permeabilization state did not enhance the detection of FITC
+
 258 
cells (data not shown), but in each case, B cells represented the dominant Na-ASP-2/FITC
+
 259 
population. 260 
 261 
Na-ASP-2 induces substantial changes in B cell gene expression. 262 
To examine the biological effect of Na-ASP-2 on human B cells, we compared the expression of 263 
cell activation markers following polyclonal stimulation of the B cell receptor (BCR). PBMCs were 264 
treated for 4 h with 2 μg/mL Na-ASP-2, or bovine serum albumin (BSA) control and stimulated for 265 
24 h with either media, or anti-human IgM. While we did not observe appreciable differences in the 266 
expression levels of CD69, CD86, HLA-DR and CD80 on B cells exposed to Na-ASP-2 following 267 
anti-IgM treatment, we did observe slight but consistent reductions in expression of these markers 268 
when cells underwent no exogenous stimulation (Supplementary Figure 1). These data suggest 269 
that B cells can still be activated in the presence of Na-ASP-2, but in the absence of polyclonal 270 
stimulation Na-ASP-2 may limit the activation state of human B cells.  271 
 272 
In order to investigate the cascade of molecular events that follow binding of Na-ASP-2 to human B 273 
cells, we sort-purified CD19
+
 CD20
+
 B cells from one volunteer’s whole PBMC culture that was 274 
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treated with either Na-ASP-2 or media control and performed RNA-Seq and bioinformatics 275 
analyses. B cells that were cultured with Na-ASP-2 for 4 h underwent minimal changes in gene 276 
expression (37 up-regulated genes, 178 down-regulated genes compared to media control, Figure 277 
4A). After 24 h of culture, however, there was a pronounced bias toward down-regulation of gene 278 
expression in B cells that were cultured with Na-ASP-2, with 1080 significantly down-regulated 279 
genes and only 95 up-regulated genes (Figure 4B).  280 
 281 
Na-ASP-2 down-regulates expression of genes involved in multiple biological pathways. 282 
Genes whose expression was significantly altered following exposure to Na-ASP-2 were clustered 283 
according to their KEGG annotation (Figure 5). In particular, the majority of down-regulated genes 284 
could be mapped to the ‘cytokine-cytokine receptor interaction’ (ko04060) and the ‘leukocyte 285 
transendothelial migration’ (ko04670) pathways, whereas the majority of genes whose expression 286 
was up-regulated by Na-ASP-2 binding could be mapped to the ‘hematopoietic cell lineage’ 287 
(ko04640) and ‘chemokine signaling pathway’ (ko04062), respectively.  288 
 289 
Na-ASP-2 down-regulates expression of genes in the Ig receptor (CD79A) signaling pathway. 290 
While Na-ASP-2 appears to affect the expression of genes involved in multiple biological 291 
pathways, we focused on potential consequences of interactions between Na-ASP-2 and CD79A 292 
based on our earlier protein-protein interaction studies. In particular, three genes mapping to the 293 
KEGG B-cell receptor signaling pathway, i.e. lyn, spleen tyrosine kinase (syk) and 294 
phosphatidylinositol 3-kinase (pi3k) displayed significant down-regulation following exposure to 295 
Na-ASP-2 (Figure 6). Each of these gene products are involved in transmitting signals from the 296 
BCR and are crucial for essential B-cell functions such as activation, development, proliferation, 297 
inhibition and cell death. 298 
 299 
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Follow-up studies involving the analysis of B cell-intrinsic gene expression induced by Na-ASP-2 300 
from four hookworm-naïve blood donors were performed using qPCR. Consistent with our findings 301 
from RNA-seq, the expression levels of both lyn and pi3k were significantly reduced in B cells that 302 
were cultured for 24 h with Na-ASP-2 ex vivo relative to control cells (Figure 7). 303 
 304 
DISCUSSION 305 
Advances in genomics and proteomics have served to highlight how little we know about the 306 
functional interactions of parasitic helminth proteins with their respective hosts tissues [32]. 307 
Approaches aimed at developing a “portfolio” for a specific pathogen protein of unknown function 308 
have provided information on expression, localization and immunogenicity [33]. None of these 309 
approaches, however, specifically addresses biochemical function or ligand/receptor interactions. 310 
The ES proteins of helminths from diverse phyla have been characterized using proteomics. 311 
However, despite the availability of draft genomes for some of these organisms, >50% of genes 312 
encoding secreted proteins remain functionally uncharacterized. This is true for N. americanus, 313 
where 33% of the genome encodes for putatively secreted proteins, but greater than 30% remain un-314 
annotated [34].  315 
 316 
N. americanus modulates the human host’s immune system to facilitate its migration from the skin 317 
to the lungs en route to the intestine [35]. Immuno-epidemiological studies from human populations 318 
have shown that protective acquired immunity to hookworm does not develop in most individuals 319 
[36]. One of the means by which hookworms modulate the host’s immune system is via the 320 
production of ES proteins [37-40]. The results from our study are consistent with this theory, where 321 
we demonstrate that Na-ASP-2 interacts with CD79A on human B lymphocytes, suppressing 322 
expression of genes that play key roles in multiple biological pathways, including the BCR 323 
signaling pathway. While the precise biological function of Na-ASP-2/B cell interactions in vivo 324 
remains unclear, our in vitro data implies that Na-ASP-2 engages CD79A and results in suppression 325 
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of molecules that determine the activation state of B cells. Our findings neither support nor 326 
contradict those of Bower [15] who showed that Na-ASP-2 recruits neutrophils. While neutrophils 327 
are essential effector cells in acute infections, they also suppress B and T cell responses by 328 
competing for antigen with professional antigen presenting cells [41]. Moreover, neutrophils 329 
indirectly regulate dendritic cell and T cell interactions [42]. Therefore, Na-ASP-2 might serve to 330 
suppress immune responses via two distinct but convergent pathways. 331 
 332 
In the absence of experimental three-dimensional structures of Na-ASP-2 in complex with host 333 
proteins, we generated a model of the Na-ASP-2:CD79A:CD79B hetero-trimer complex.  This 334 
model is in agreement with two previously reported findings. First, the interaction interface between 335 
the hookworm protein and the CD79 hetero-dimer has a His/Gln-containing motif with similar 336 
properties to those identified by panning a random peptide library with Na-ASP-2 [31]. Second, the 337 
vast majority of the interaction interface of Na-ASP-2 and CD79 is on the -subunit, coinciding 338 
with the interaction interface of CD79 with membrane immunoglobulin [22]. We recently identified 339 
the human SK3 channel as a putative receptor of Na-ASP-2 based on the presence of a His/Gln-rich 340 
peptide that interacted with Na-ASP-2 in vitro [31]. Since this His/Gln peptide sequence is only 341 
present in one of the isoforms of the SK3 channel (isoform 1), and the human V5 ProtoArray 342 
included isoform 2, no interactions with SK3 were observed in this study. 343 
 344 
The human BCR consists of a 1:1 stoichiometry of membrane-bound immunoglobulin and 345 
CD79A/CD79B. The immunoglobulin domain relies on a non-covalent association with the 346 
CD79A/CD79B heterodimer complex for triggering a signaling cascade [43]. Upon binding of 347 
antigen to membrane bound immunoglobulin, the receptor complex undergoes conformational 348 
changes, resulting in recruitment of LYN, phosphorylation of the relevant CD79 tyrosines, PI3K 349 
recruitment to CD19 and adaptor proteins, and generation of the potent lipid secondary messenger 350 
phosphatidylinositol 3,4,5-trisphosphate (PIP3). How interactions between CD79A and Na-ASP-2 351 
 15 
result in down-regulated expression of lyn and pi3k is unclear, but it is possible that Na-ASP-2 may 352 
induce an anergic-like state in B cells by preventing BCR clustering and activation of the cell upon 353 
antigen binding. Anergic B cells are characterized by impaired propagation of activating signals 354 
that are triggered by CD79 engagement [44], substantially reduced PIP3 production [45] and have a 355 
dramatically reduced lifespan. While Na-ASP-2 does not limit the capacity for B cells to be 356 
activated by polyclonal stimulation, the activation state of “resting” B cells appeared to be lowered. 357 
Further studies are required to determine if Na-ASP-2 can regulate the B cell-intrinsic responses to 358 
more physiologically relevant antigens, particularly ES proteins. Hookworms are known to induce a 359 
state of immune hypo-responsiveness in chronic infections [36, 46], and by probing a hookworm 360 
protein microarray [34] we found that the most heavily infected individuals generated lower IgG 361 
responses than did individuals with low or moderate intensity infections (S. Gaze & A. Loukas, 362 
unpublished). These findings serve to highlight the altered B cell functions in individuals with 363 
heavy hookworm infection, and offer a potential causative role for proteins such as Na-ASP-2, 364 
however this hypothesis requires rigorous testing, potentially in well-controlled hookworm dose-365 
ranging studies [47]. 366 
 367 
To our knowledge this is the first report of a pathogen protein that interacts with the BCR, or 368 
modulates expression of signaling molecules that determine B-cell function. Given the interest in 369 
hookworm-secreted proteins for treating autoimmune and allergic diseases [40, 48], our findings 370 
suggest that Na-ASP-2 warrants testing as a novel biologic for treating B cell-mediated 371 
autoimmunity. Administration of anti-CD79 or anti-CD79B monoclonal antibodies prevent 372 
collagen-induced arthritis [49] or lupus [50], respectively in mice, offering the potential for reduced 373 
side effects whilst maintaining B cells in a transient anergic state that does not require their 374 
depletion. Thus, Na-ASP-2 could prove beneficial as a treatment for autoimmune B cell-mediated 375 
diseases such as Multiple Sclerosis or rheumatoid arthritis. 376 
 377 
 16 
Our findings herein highlight the novel application of protein microarray technology to addressing 378 
host-hookworm interactions at the protein level, and provide a powerful and rapid screening process 379 
that could be applied to the study and identification of interactions between other pathogens and 380 
host proteins. By coupling the probing of the human proteome array with ex vivo confirmation of 381 
binding to live cells and subsequent NGS to determine changes in gene expression, we have 382 
demonstrated the utility of this pipeline for elucidating novel host-pathogen interactions and 383 
assigning functions to that enigmatic group of pathogen molecules that are frustratingly referred to 384 
as “proteins of unknown function”. 385 
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FIGURE LEGENDS 513 
Figure 1. Binding of biotinylated Na-ASP-2 to CD79A and biotin-binding proteins on a 514 
Human V5 ProtoArray. The array was probed with biotinylated recombinant Na-ASP-2 followed 515 
by streptavidin Alexafluor 647 and scanned using a GeneArray 4000B scanner at 635 nm using 516 
laser intensity settings of 100% (A) and 66% (B). Yellow boxes denote the area of the array 517 
containing duplicate spots of CD79A and PCCA. Panel C shows a magnified view of the area 518 
contained within the yellow boxes. All other spots are positive control proteins spotted in duplicate 519 
to allow orientation on the array. Two separate arrays were probed independently, with 520 
representative results from one experiment displayed. 521 
 522 
Figure 2. Rigid body models of the CD79A/CD79B heterodimer (A) and the 523 
CD79A/CD79B:Na-ASP-2 complex (B). CD79A is coloured wheat, CD79B pale green, and Na-524 
ASP-2 is coloured magenta. Cysteine residues and disulphide bonds are rendered as sticks in 525 
yellow. The CD79A peptide HFQCPH (residues 51-56) is coloured blue. Surface representation of 526 
the CD79 heterodimer model (A). Cartoon rendering of the modelled ternary complex of Na-ASP-2 527 
and CD79 (B).  528 
 529 
Figure 3. Na-ASP-2 binds selectively to human B-cells. PBMCs from hookworm-naïve donor 530 
volunteers were cultured for 24 h in the presence of increasing concentrations of biotinylayed 531 
recombinant Na-ASP-2, or with unlabeled Na-ASP-2. (A) Frequencies of cells with biotinylated 532 
Na-ASP-2 on the surface were quantified by flow cytometry after incubation with FITC-conjugated 533 
streptavidin. (B) Na-ASP-2
+
 FITC
+
 cells were gated for analysis of the immune cell-surface 534 
markers CD3, CD14, CD20 and CD19. Experiments were conducted twice, with two different 535 
blood donors; representative data are shown.  536 
 537 
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Figure 4. Changes in mRNA expression in B cells from a hookworm-naïve human volunteer 538 
after culture with Na-ASP-2. PBMCs were cultured for 4 or 24 h with either media or 2 μg.ml-1 539 
Na-ASP-2; CD19
+
 CD20
+
 B cells were sort purified and isolated RNA was subjected to RNA Seq 540 
analysis. Scatter plots comparing log2 ratios of RPKM expression values for B cells from a 541 
hookworm-naïve human volunteer following ex vivo co-culture with Na-ASP-2 at 4 and 24 hours. 542 
Numbers indicate the numbers of up or down-regulated genes. 543 
 544 
Figure 5. Differential gene expression following 24 h exposure to Na-ASP-2. Heatmap analysis 545 
of differentially expressed genes following 24 h culture of sort-purified human B cells with Na-546 
ASP-2. Differentially expressed genes are clustered according to their KEGG annotation. The top 547 
KEGG pathways assigned to the majority of genes within each cluster are also reported. 548 
 549 
Figure 6. Na-ASP2 causes B-cell intrinsic reductions in expression of mRNAs immediately 550 
downstream of CD79A. Schematic representation of the B cell receptor signaling pathway 551 
(modified from http://www.genome.jp/kegg-bin/show_pathway?hsa04662). Genes whose 552 
expression was down-regulated following 24 h -co-culture of B cells with Na-ASP-2 are indicated 553 
by green boxes. 554 
 555 
Figure 7. Down-regulated expression of lyn and pi3k in human B cells from four hookworm-556 
naïve human volunteers after culture with Na-ASP-2. PBMCs from four hookworm-naïve donor 557 
volunteers were cultured for 24 h in the presence of medium alone or 2 μg.ml-1 recombinant Na-558 
ASP-2. qPCR analysis of lyn and pi3kR5 was performed on RNA derived from sort-purified B cells. 559 
Data were analyzed using the ΔΔCT method (Relative quantification, RQ), whereby actin served as 560 
the endogenous gene and samples were normalized to media controls. *P = 0.0295; **P = 0.0004. 561 
 24 
Supplementary Figure 1: Impact of Na-ASP-2 on B cell expression of activation surface 562 
markers following anti-IgM-stimulation and in the steady-state. PBMCs from hookworm-naïve 563 
volunteers were pre-incubated for 4 h with 2 μg/mL of either a control protein (BSA) or Na-ASP-2 564 
prior to incubation for 24 h with 10 μg/ml goat F(ab’)2 anti-mouse IgM or media alone (No 565 
treatment). Surface marker expression on gated CD19
+
 CD20
+
 B cells was compared by flow 566 
cytometry. Color-coded numbers in each inset represents mean fluorescense intensity for each 567 
marker. The experiment was performed twice, with a different blood donor each time; 568 
representative data are shown. 569 
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Supplementary Table 1- List of proteins on the Human V5 ProtoArray that 
interacted with recombinant Na-ASP-2. 
Intensity Protein NCBI code Description 
1600 Propionyl coenzyme A 
carboxylase (PCCA) 
NM_000282.1 Biotin binding enzyme 
456.5 Immunoglobulin binding protein 
1 (IGBP1/CD79a) 
NM_001551.1 Co-receptor of B-cell receptor 
complex 
359.5 Methylcrotonoyl-Coenzyme A 
carboxylase 1 (alpha) (MCCC1) 
NM_020166.2 Biotin metabolism 
191.5 Cortactin (CTTN), transcript 
variant 2, intracellular 
NM_138565.1 Actin remodelling enzyme 
177.5 Enoyl-Coenzyme A, hydratase/3-
hydroxyacyl Coenzyme A 
dehydrogenase (EHHADH) 
BC000306.1 Biotin metabolism 
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